48 filings
Page 2 of 3
8-K
zd6y36h8bgwele28nuql
26 Jun 20
Entry into a Material Definitive Agreement
4:06pm
8-K
s67ycvjnuxdx
22 Jun 20
Entry into a Material Definitive Agreement
5:26pm
8-K
vq37o ykcxa6spq5ly
5 Jun 20
Regulation FD Disclosure
4:05pm
8-K
qv4oerixb5lhxjbnxs9m
19 May 20
Cue Biopharma Reports First Quarter 2020 Results, Updates ofCUE-101 Phase 1 Dose Escalation Study and Recent Business Highlights
4:06pm
8-K
kplqsbjj
27 Mar 20
Entry into a Material Definitive Agreement
4:53pm
8-K
82ijy
17 Mar 20
Cue Biopharma Reports Fourth Quarter and Full Year 2019 Financial Results
4:23pm
8-K
hqx87kk b36
2 Mar 20
Regulation FD Disclosure
4:22pm
8-K
jgpzi33sum og8q0c
10 Feb 20
Entry into a Material Definitive Agreement
4:01pm
8-K
tz9so0t a4mb
26 Nov 19
Entry into a Material Definitive Agreement
12:00am
8-K
ujy40qrd cu0j5cmloj
12 Nov 19
Cue Biopharma Reports Third Quarter 2019 Financial Results
4:05pm
8-K
uqir8
9 Oct 19
Departure of Directors or Certain Officers
4:06pm
8-K
lzj8eje8226k
7 Oct 19
Entry into a Material Definitive Agreement
4:42pm
8-K
8oulur8ux2vt
6 Aug 19
Departure of Directors or Certain Officers
4:49pm
8-K
a3no3ft8cr28gq
5 Jun 19
Entry into a Material Definitive Agreement
8:55am
8-K/A
qo2sgm5syfbykp
26 Dec 18
Cue Biopharma and LG Chem Life Sciences Announce WT1
4:31pm
8-K/A
4o9 vic020ep455lk6lm
13 Nov 18
Entry into a Material Definitive Agreement
4:22pm
8-K
m6nb9d
8 Nov 18
Entry into a Material Definitive Agreement
8:13am
8-K
l1xhsv3eq 8ktp
3 Aug 18
Departure of Directors or Certain Officers
4:05pm
8-K
0fjgxyu5e9acwa3ooji
12 Jul 18
Cue Biopharma Produces Immuno-STATTM Biologic Candidate for Treatment of Autoimmune Disease Under Collaboration and License Agreement with Merck
8:40am
8-K
ikjtcigk
26 Jun 18
Departure of Directors or Certain Officers
4:16pm